Update in Cardiology: Vascular Risk and Cardiac Rehabilitation

As in other fields, understanding of vascular risk and rehabilitation is constantly improving. The present review of recent epidemiological update shows how far we are from achieving good risk factor control: in diet and nutrition, where unhealthy and excessive societal consumption is clearly increa...

Descripción completa

Detalles Bibliográficos
Autores: Galve, E, Cordero, A, Bertomeu-Martinez, V, Facila, L, Mazon, P, Alegria, E, de Bobadilla, JF, Garcia-Porrero, E, Martinez-Selles, M, Gonzalez-Juanatey, JR
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p8378
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/8378
Access Level:acceso abierto
Palabra clave:Update
Risk factors
Physical exercise
Smoking
Hypertension
Diabetes
id ES_bb66f0e3e5cec548d2e11602df6281f1
oai_identifier_str oai:fisabio.fundanetsuite.com:p8378
network_acronym_str ES
network_name_str España
repository_id_str
spelling Update in Cardiology: Vascular Risk and Cardiac RehabilitationGalve, ECordero, ABertomeu-Martinez, VFacila, LMazon, PAlegria, Ede Bobadilla, JFGarcia-Porrero, EMartinez-Selles, MGonzalez-Juanatey, JRUpdateRisk factorsPhysical exerciseSmokingHypertensionDiabetesAs in other fields, understanding of vascular risk and rehabilitation is constantly improving. The present review of recent epidemiological update shows how far we are from achieving good risk factor control: in diet and nutrition, where unhealthy and excessive societal consumption is clearly increasing the prevalence of obesity; in exercise, where it is difficult to find a balance between benefit and risk, despite systemization efforts; in smoking, where developments center on programs and policies, with the electronic cigarette seeming more like a problem than a solution; in lipids, where the transatlantic debate between guidelines is becoming a paradigm of the divergence of views in this extensively studied area; in hypertension, where a nonpharmacological alternative (renal denervation) has been undermined by the SYMPLICITY HTN-3 setback, forcing a deep reassessment; in diabetes mellitus, where the new dipeptidyl peptidase-4 and sodium-glucose cotransporter type 2 inhibitors and glucagon like peptide 1 analogues have contributed much new information and a glimpse of the future of diabetes treatment, and in cardiac rehabilitation, which continues to benefit from new information and communication technologies and where clinical benefit is not hindered by advanced diseases, such as heart failure. Our summary concludes with the update in elderly patients, whose treatment criteria are extrapolated from those of younger patients, with the present review clearly indicating that should not be the case. (C) 2014 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.EDICIONES DOYMA S A2015info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fisabio.portalinvestigacion.com/publicaciones/8378REVISTA ESPANOLA DE CARDIOLOGIAISSN: 03008932ISSNe: 15792242reponame:r-FISABIO. Repositorio Institucional de Producción Científicainstname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)Españolinfo:eu-repo/semantics/openAccessoai:fisabio.fundanetsuite.com:p83782026-06-11T12:45:17Z
dc.title.none.fl_str_mv Update in Cardiology: Vascular Risk and Cardiac Rehabilitation
title Update in Cardiology: Vascular Risk and Cardiac Rehabilitation
spellingShingle Update in Cardiology: Vascular Risk and Cardiac Rehabilitation
Galve, E
Update
Risk factors
Physical exercise
Smoking
Hypertension
Diabetes
title_short Update in Cardiology: Vascular Risk and Cardiac Rehabilitation
title_full Update in Cardiology: Vascular Risk and Cardiac Rehabilitation
title_fullStr Update in Cardiology: Vascular Risk and Cardiac Rehabilitation
title_full_unstemmed Update in Cardiology: Vascular Risk and Cardiac Rehabilitation
title_sort Update in Cardiology: Vascular Risk and Cardiac Rehabilitation
dc.creator.none.fl_str_mv Galve, E
Cordero, A
Bertomeu-Martinez, V
Facila, L
Mazon, P
Alegria, E
de Bobadilla, JF
Garcia-Porrero, E
Martinez-Selles, M
Gonzalez-Juanatey, JR
author Galve, E
author_facet Galve, E
Cordero, A
Bertomeu-Martinez, V
Facila, L
Mazon, P
Alegria, E
de Bobadilla, JF
Garcia-Porrero, E
Martinez-Selles, M
Gonzalez-Juanatey, JR
author_role author
author2 Cordero, A
Bertomeu-Martinez, V
Facila, L
Mazon, P
Alegria, E
de Bobadilla, JF
Garcia-Porrero, E
Martinez-Selles, M
Gonzalez-Juanatey, JR
author2_role author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Update
Risk factors
Physical exercise
Smoking
Hypertension
Diabetes
topic Update
Risk factors
Physical exercise
Smoking
Hypertension
Diabetes
description As in other fields, understanding of vascular risk and rehabilitation is constantly improving. The present review of recent epidemiological update shows how far we are from achieving good risk factor control: in diet and nutrition, where unhealthy and excessive societal consumption is clearly increasing the prevalence of obesity; in exercise, where it is difficult to find a balance between benefit and risk, despite systemization efforts; in smoking, where developments center on programs and policies, with the electronic cigarette seeming more like a problem than a solution; in lipids, where the transatlantic debate between guidelines is becoming a paradigm of the divergence of views in this extensively studied area; in hypertension, where a nonpharmacological alternative (renal denervation) has been undermined by the SYMPLICITY HTN-3 setback, forcing a deep reassessment; in diabetes mellitus, where the new dipeptidyl peptidase-4 and sodium-glucose cotransporter type 2 inhibitors and glucagon like peptide 1 analogues have contributed much new information and a glimpse of the future of diabetes treatment, and in cardiac rehabilitation, which continues to benefit from new information and communication technologies and where clinical benefit is not hindered by advanced diseases, such as heart failure. Our summary concludes with the update in elderly patients, whose treatment criteria are extrapolated from those of younger patients, with the present review clearly indicating that should not be the case. (C) 2014 Sociedad Espanola de Cardiologia. Published by Elsevier Espana, S.L.U. All rights reserved.
publishDate 2015
dc.date.none.fl_str_mv 2015
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fisabio.portalinvestigacion.com/publicaciones/8378
url https://fisabio.portalinvestigacion.com/publicaciones/8378
dc.language.none.fl_str_mv Español
language_invalid_str_mv Español
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv EDICIONES DOYMA S A
publisher.none.fl_str_mv EDICIONES DOYMA S A
dc.source.none.fl_str_mv REVISTA ESPANOLA DE CARDIOLOGIA
ISSN: 03008932
ISSNe: 15792242
reponame:r-FISABIO. Repositorio Institucional de Producción Científica
instname:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
instname_str Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
reponame_str r-FISABIO. Repositorio Institucional de Producción Científica
collection r-FISABIO. Repositorio Institucional de Producción Científica
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869418022587858944
score 15,811543

Similares en LA Referencia